Saturday, November 08, 2014 6:12:29 PM
Posted on November 4, 2014 by Marc Robinson-Rechavi
In this first session of the course “Sequence a genome” since we sent DNA to the sequencing facility, we have had the visit of Gerrit Kuhn, who supports PacBio in our area, and who gave a nice presentation of how PacBio works, the workflow, and of the specific requirements during sample preparation and how it influences data quality. While the sleek animations are expected from a corporate presentation, kudos to Gerrit for being open and giving insight into the advantages and specificities of the PacBio workflow, and answering all questions straightforwardly. (Updated paragraph.)
( A new adventure: PacBio sequencing and RNA-seq in the classroom)
Gerrit Kuhn of PacBio Switzerland talking some more to our students.
After our first pass of PacBio, we have 9 contigs, with the longest at 5’815’706 bp. We have asked the students to use Mauve to look at our assembly, and compare it to a version of the Pseudomonas veronii genome in NCBI, which has 63 contigs.
Screenshot of Mauve comparison of our contigs (top) with the NCBI genome (bottom). Red lines separate contigs, colored blocks are recognized as similar between the two genomes.
We have two very large contigs, unitig-3 and -5, with strong similarity to the NCBI genome, and some other contigs with almost none. Notice the spaghetti of relations between contig blocks, due to the fragmented assembly in the NCBI genome. We also compared our contigs between themselves. We are thus able to eliminate 3 contigs which are small and entirely redundant with larger contigs within our assembly. We can also find that the two largest contigs have enough overlap to join them, which provides us a main chromosome of 6.8 Mb. We are not able to circularize it, though. Two other groups of contigs can be joined into additional molecules, plasmids or secondary chromosomes, to be determined at annotation (in a few weeks). A group of 3 contigs groups into an apparent mega-plasmid, which we can circularize thanks to similarity at the ends of the contigs; this also has high similarity to NCBI contigs. The other potential plasmid, formed of two contigs which cannot circularize, has no similarity to the NCBI sequence, and ends with potential transposons (sequences found elsewhere in the genome).
Thus overall, the PacBio experiment seems to have worked: the DNA extracted by our students and sequenced in our facility has produced a usable assembly. In the next weeks we will annotate this chromosome and these two plasmids.
http://www3.unil.ch/wpmu/sequenceagenome/2014/11/04/finishing-pacbio-assembly-and-a-presentation-by-our-local-pacbio-representative/
Recent PACB News
- Ambry Genetics and PacBio Announce Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare Diseases • PR Newswire (US) • 05/15/2024 01:45:00 PM
- Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 05/09/2024 08:33:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:21:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:12:15 PM
- PacBio Announces First Quarter 2024 Financial Results • PR Newswire (US) • 05/09/2024 08:05:00 PM
- PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance • PR Newswire (US) • 04/16/2024 12:05:00 PM
- Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes • PR Newswire (US) • 03/27/2024 12:00:00 PM
- PacBio Grants Equity Incentive Award to New Employee • PR Newswire (US) • 03/22/2024 08:30:00 PM
- PacBio Announces PureTarget™ Repeat Expansion Panel, Expanding its Portfolio of End-to-End Clinical Research Solutions • PR Newswire (US) • 03/12/2024 01:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 10:36:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 10:30:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 10:26:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 10:22:45 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 11:32:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 11:22:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:55:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:36:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:25:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:19:42 PM
- PacBio to Present at Upcoming Investor Conferences • PR Newswire (US) • 02/26/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 11:25:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 11:20:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 11:17:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 11:07:18 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/20/2024 09:17:12 PM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM